Company Name: Summit Therapeutics plc

Summit Therapeutics plc is a biopharmaceutical company. The company’s focus is on the discovery/development of therapies designed to treat Duchenne muscular dystrophy (DMD) and Clostridium difficile infection (CDI).

Ticker Symbol: SMMT (NASDAQ)

Company Website: www.summitplc.com

Social Media:

Summit Therapeutics LinkedIn

Summit Therapeutics Twitter

Headquarters: Abingdon, Oxfordshire, UK